Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: Insight from the observational multicentric ProREAL surveillance

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 32, Issue 1, 2013, Pages 51-60

  Dusemund, F ^a   Bucher, B ^a   Meyer, S ^a   Thomann, R ^b,l   Kuhn F ^c   Bassetti, S ^c   Sprenger, M ^d   Baechli, E ^d   Sigrist, T ^e   Schwietert, M ^f   Amin, D ^g   Hausfater, P ^h   Carre, E ⁱ   Schuetz, P ^j   Gaillat, J ^k   Regez, K ^a   Bossart, R ^a   Schild, U ^a   Muller B ^a   Albrich, W C ^a  

^a Medical University Department   (Switzerland)

^b Division of Medicine   (Switzerland)

^c Division of Medicine   (Switzerland)

^d Division of Medicine   (Switzerland)

^e Klinik Barmelweid   (Switzerland)

^f Kantonsspital Liestal   (Switzerland)

^g Morton Plant Hospital   (United States)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁱ Hospitalier de la Région d'Annecy ^*

^j HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^k Maladies Infectieuses   (France)

^l UNIVERSITY HOSPITAL BASEL   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROCALCITONIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PROTOCOL; COMMUNITY ACQUIRED PNEUMONIA; DISEASE EXACERBATION; EUROPE; FRANCE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MEDICAL DECISION MAKING; OBSERVATIONAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; SWITZERLAND;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CALCITONIN; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; FRANCE; GUIDELINE ADHERENCE; HUMANS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RESPIRATORY TRACT INFECTIONS;

EID: 84872613382     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1713-8     Document Type: Article

References (39)

1. Grill MF, Maganti RK (2011) Neurotoxic effects associated with antibiotic use: management considerations. BJCP 72(3):381-93
2. Stewardson AJ, Huttner B, Harbarth S (2011) At least it won't hurt: the personal risks of antibiotic exposure. Curr Opin Pharmacol 11(5):446-52
3. Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E (2011) Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. CID 53(1):42-8
4. Harbarth S, Emonet S (2006) Navigating the World Wide Web in search of resources on antimicrobial resistance. CID 43(1):72-8
5. Van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H et al (2008) Antimicrobial drug use and resistance in Europe. EID 14(11):1722-30
6. Albrich WC, Monnet DL, Harbarth S (2004) Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. EID 10(3):514-517
7. Dagan R, Barkai G, Givon-Lavi N, Sharf AZ, Vardy D, Cohen T et al (2008) Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy? JID 197(8):1094-1102
8. Nasrin D, Collignon PJ, Roberts L, Wilson EJ, Pilotto LS, Douglas RM (2002) Effect of beta lactam antibiotic use in children on pneumococcal resistance to penicillin: prospective cohort study. BMJ 324(7328):28-30
9. Carmeli Y, Troillet N, Karchmer AW, Samore MH (1999) Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Int Med 159(10):1127-1132
10. Cosgrove SE, Carmeli Y (2003) The impact of antimicrobial resistance on health and economic outcomes. CID 36(11):1433-1437
11. Cosgrove SE (2006) The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. CID 42(Suppl 2):S82-89
12. Spellberg B (2011) The antibiotic crisis: can we reverse 65 years of failed stewardship? Arch Int Med 171(12):1080-1081
13. Cars O, Molstad S, Melander A (2001) Variation in antibiotic use in the European Union. Lancet 357(9271):1851-1853
14. Harbarth S, Albrich W, Goldmann DA, Huebner J (2001) Control of multiply resistant cocci: do international comparisons help? Lancet Infect Dis 1(4):251-261
15. Finch RG, Metlay JP, Davey PG, Baker LJ, International Forum on Antibiotic Resistance (2002) Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infect Dis 4(1):44-53
16. Hulscher ME, Grol RP, van der Meer JW (2010) Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis 10(3):167-175
17. Harbarth S, Albrich W, Brun-Buisson C (2002) Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. EID 8(12):1460-1467
18. Filippini M, Masiero G, Moschetti K (2006) Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Healthpol 78(1):77-92
19. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M et al (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363(9409)
20. Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR et al (2006) Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. AJRCCM 174(1):84-93
21. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I et al (2009) Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 302(10):1059-1066
22. Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C et al (2010) Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375(9713):463-474
23. Schuetz P, Batschwaroff M, Dusemund F, Albrich W, Burgi U, Maurer M et al (2010) Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey. EJCMID 29(3):269-277
24. Schuetz P, Albrich W, Christ-Crain M, Chastre J, Mueller B (2010) Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther 8(5):575-587
25. Albrich WC, Dusemund F, Bucher B, Meyer S, Thomann R, Kuehn F, Bassetti S, Sprenger M, Bachli E, Sigrist T, Schwietert M, Amin D, Hausfater P, Carre E, Gaillat J, Schuetz P, Regez K, Bossart R, Schild U, Mueller B (2012) Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life" - an international, multicenter poststudy survey (ProREAL). Arch Int Med 172(9):715-722
26. Schuetz P, Christ-Crain M, Wolbers M, Schild U, Thomann R, Falconnier C et al (2007) Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. BMC Health Serv Res 7:102
27. Fischer JE, Harbarth S, Agthe AG, Benn A, Ringer SA, Goldmann DA et al (2004) Quantifying uncertainty: physicians' estimates of infection in critically ill neonates and children. CID 38(10):1383-1390
28. Bartlett JG (2011) Diagnostic tests for agents of community-acquired pneumonia. CID 52(S4):296-304
29. Schwartz A (2011) Medical decision making and medical education: challenges and opportunities. Perspect Biol Med 54(1):68-74
30. Gonzales R, Sande MA (2000) Uncomplicated acute bronchitis. Ann Int Med 133(12):981-991
31. Gonzales R, Steiner JF, Sande MA (1997) Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 278(11):901-904
32. Wenzel RP, Fowler AA (2006) Clinical practice. Acute bronchitis. N Engl J Med 355(20):2125-2130
33. Sabuncu E, David J, Bernede-Bauduin C, Pepin S, Leroy M, Boelle PY et al (2009) Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Medicine 6(6):e1000084
34. Huttner B, Goossens H, Verheij T et al (2010) Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. The Lancet ID 10(1):17-31
35. Aujesky D, McCausland JB, Whittle J, Obrosky DS, Yealy DM, Fine MJ (2009) Reasons why emergency department providers do not rely on the pneumonia severity index to determine the initial site of treatment for patients with pneumonia. CID 49(10):e100-108
36. Grol R, Grimshaw J (1999) Evidence-based implementation of evidence-based medicine. Joint Comm J Qual Im 25(10):503-513
37. Hannes K, Leys M, Vermeire E, Aertgeerts B, Buntinx F, Depoorter AM (2005) Implementing evidence-based medicine in general practice: a focus group based study. BMC Fam Pract 6:37
38. Kitto S, Petrovic A, Gruen RL, Smith JA (2011) Evidence-based medicine training and implementation in surgery: the role of surgical cultures. JECP 17(4):819
39. Haspel RL (2010) Implementation and assessment of a resident curriculum in evidence-based transfusion medicine. Arch Pathol Lab Med 134(7):1054-1059